Market Trends– category –
-
Liv Hospital Details Advanced ‘Off-the-Shelf’ CAR-T Manufacturing, Promising Scalability and Broader Access
Liv Hospital Turkey Overview Liv Hospital has unveiled its detailed manufacturing process for allogeneic, 'off-the-shelf' CAR-T cell therapy, a significant leap towards overcoming the logistical and cost barriers of current personalized ... -
Closed, Automated Culture Systems Critical for iPSC Therapy Manufacturing to Ensure GMP and Scalability
Contract Pharma USA Overview iPSC-derived cell therapies are rapidly emerging as scalable solutions across regenerative medicine and oncology, yet ensuring GMP-grade production and consistency across large-scale manufacturing platforms r... -
Biopharmaceutical CDMO Capacity Crunch Persists, Driving Rapid Expansion in Cell and Gene Therapy Production
Contract Pharma USA Overview The biopharmaceutical industry continues to face a CDMO capacity crunch, prompting contract development and manufacturing organizations to heavily invest in expanding production capabilities, particularly for... -
In Vivo CAR T-Cell Therapy KLN-1010 Achieves 100% MRD Negativity in Multiple Myeloma Phase 1 Trial, Presented at ASCO/EHA 2026
International Myeloma Foundation USA Overview At the 2026 ASCO and EHA meetings, groundbreaking results for KLN-1010, an in vivo CAR T-cell therapy eliminating the need for ex vivo T-cell harvest, were highlighted. The clinical trial in ... -
CSPC Pharmaceutical and AstraZeneca Form Joint Venture for AI-Driven GMP Biologics Manufacturing Facility in China
BioPharm International China Overview CSPC Pharmaceutical Group and AstraZeneca have signed a joint venture agreement to construct a next-generation biopharmaceutical manufacturing facility in Shijiazhuang, China. This facility aims to i... -
Japan Establishes Rigorous Regulatory Framework for Stem Cell and Regenerative Medicine under ASRM
PlacidWay Japan Overview Japan has implemented a stringent regulatory framework for stem cell therapy and regenerative medicine, based on the Act on the Safety of Regenerative Medicine (ASRM). The Ministry of Health, Labour and Welfare (... -
SFC Energy Achieves Record H1 2026 Revenue with 47.1% Gross Margin, Driven by Increased Fuel Cell Orders to Ukraine
S&P Global (Market Intelligence) Germany Overview SFC Energy posted record results for H1 2026, with revenue up 12% year-over-year and gross profit margin reaching a significantly improved 47.1%. Growth was driven by the clean energy seg... -
Fuel Cell Energy’s SOFC Achieves Commercial Maturity for AI Data Center On-Site Power Demand
EnkiAI USA Overview 2026 marked a pivotal year as data center developers aggressively adopted on-site fuel cell technology to address surging AI data center power demand and existing grid constraints. Fuel Cell Energy's Solid Oxide Fuel ... -
Fusion Fuel Green Subsidiary Marks Major Milestones in Southern European Green Hydrogen Deployments
Markets Insider Portugal Overview Bright Hydrogen Solutions Limited (BrightHy Solutions), a wholly-owned subsidiary of Fusion Fuel Green, has successfully advanced two critical green hydrogen projects in Southern Europe. The company comp... -
U.S. DOE Allocates $62M to 20 Projects Across 15 States to Advance National Clean Hydrogen Strategy
U.S. Department of Energy (DOE) USA Overview The U.S. Department of Energy (DOE) announced it will allocate approximately $62 million to 20 projects across 15 states to accelerate research, development, demonstration, and deployment of n...
